share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：拟议出售证券
美股sec公告 ·  06/13 16:16
Moomoo AI 已提取核心信息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/13/2024, with an aggregate market value of $139,798.24. The shares to be sold were acquired through restricted stock vesting and stock option exercise on 05/15/2023 and 06/13/2023, respectively. The securities were obtained directly from the issuer as part of compensation and cash payment. This planned transaction follows a series of sales over the past three months, where a total of 73,124 shares were sold for gross proceeds of $642,823.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 06/13/2024, with an aggregate market value of $139,798.24. The shares to be sold were acquired through restricted stock vesting and stock option exercise on 05/15/2023 and 06/13/2023, respectively. The securities were obtained directly from the issuer as part of compensation and cash payment. This planned transaction follows a series of sales over the past three months, where a total of 73,124 shares were sold for gross proceeds of $642,823.
Recursion Pharmaceuticals, Inc.官员Secora Michael计划于2024年06月13日出售15000股A类股票，市值为$139,798.24。拟售出的股票是通过限制性股票归属和2023年05月15日和2023年06月13日的股票期权行使获取的，这些证券是作为补偿和现金支付的一部分直接从发行人获得。这次计划中的交易是在过去三个月内一系列销售之后进行的，总共售出73124股获得总收入为$642,823。
Recursion Pharmaceuticals, Inc.官员Secora Michael计划于2024年06月13日出售15000股A类股票，市值为$139,798.24。拟售出的股票是通过限制性股票归属和2023年05月15日和2023年06月13日的股票期权行使获取的，这些证券是作为补偿和现金支付的一部分直接从发行人获得。这次计划中的交易是在过去三个月内一系列销售之后进行的，总共售出73124股获得总收入为$642,823。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息